Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 11;7(1):7984.
doi: 10.1038/s41598-017-06628-8.

The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis

Affiliations
Meta-Analysis

The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis

Shaun Wen Huey Lee et al. Sci Rep. .

Abstract

Benign prostatic hyperplasia is a common non-malignant condition among older men, but the epidemiology is poorly characterised. We summarised and determined the global prevalence of benign prostatic hyperplasia. A systematic search on PubMed, EMBASE and CENTRAL was performed up until 31st July 2016. Studies that described the epidemiology of benign prostatic hyperplasia were included and cumulative plots of prevalence estimates were calculated. A total of 31 prevalence rate estimates from 25 countries were identified. The combined prevalence estimates showed that the lifetime prevalence of BPH was 26.2% (95% CI: 22.8-29.6%). We found that there was an increasing prevalence of BPH with age. However, we found no significant difference between (a) rural, urban or mixed sites, (b) different countries, (c) respondent representativeness. (d) sample size or (e) study quality. We also found no significant change in the prevalence over the past 20 years. While there is substantial variation between sites estimates, results suggest that nearly 1 in 4 men will suffer from BPH over their lifetime. The study revealed there are significant gaps in knowledge, which provides opportunities for future research to further enrich the epidemiological landscape with data.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Flow of the study.
Figure 2
Figure 2
Unadjusted benign prostatic hyperplasia prevalence based across different age groups.
Figure 3
Figure 3
Benign prostatic hyperplasia prevalence by year of data collection.

References

    1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: Benign prostatic hyperplasia. Journal of Urology. 2005;173:1256–1261. doi: 10.1097/01.ju.0000155709.37840.fe. - DOI - PubMed
    1. McVary, K. T. et al. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. The Journal of Urology185, 1793–1803, doi:10.1016/j.juro.2011.01.074. - PubMed
    1. Parsons JK, et al. Lower urinary tract symptoms increase the risk of falls in older men. Bju International. 2009;104:63–68. doi: 10.1111/j.1464-410X.2008.08317.x. - DOI - PMC - PubMed
    1. Mirone V, et al. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events. Int J Clin Pract. 2011;65:1005–1013. doi: 10.1111/j.1742-1241.2011.02731.x. - DOI - PubMed
    1. Kaplan AL, et al. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC) Healthcare. 2015;3:43–48. doi: 10.1016/j.hjdsi.2014.09.007. - DOI - PubMed